NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 172 filers reported holding NOVAVAX INC in Q4 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $847,000 | -44.1% | 1,537,130 | +86.7% | 0.03% | -45.3% |
| Q4 2018 | $1,515,000 | -2.1% | 823,378 | 0.0% | 0.05% | +20.5% |
| Q3 2018 | $1,548,000 | +40.3% | 823,378 | 0.0% | 0.04% | +37.5% |
| Q2 2018 | $1,103,000 | -36.2% | 823,378 | 0.0% | 0.03% | -36.0% |
| Q1 2018 | $1,729,000 | +36.2% | 823,378 | -19.5% | 0.05% | +38.9% |
| Q4 2017 | $1,269,000 | +52.5% | 1,023,378 | +41.5% | 0.04% | +50.0% |
| Q3 2017 | $832,000 | – | 723,378 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
| GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
| SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
| Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
| BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
| GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
| CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
| Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |